Psychosocial Treatments for People with Co-occurring Severe Mental Illnesses and Substance Use Disorders (Dual Diagnosis): A Review of Empirical Evidence

REFERENCES

• Burnam M A, Watkins K E. Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff 2006; 25: 648–58
   PubMed Web of Science ®Google Scholar
• Drake R E, Goldman H H, Leff H S, et al. Implementing evidence-based practices in routine mental health service settings. Psychiatr Serv 2001; 52: 179–82
   PubMed Web of Science ®Google Scholar
• Todd J, Green G, Harrison M, et al. Defining dual diagnosis of mental illness and substance misuse: some methodological issues. J Psychiatr Ment Health Nurs 2004; 11: 48–54
   PubMedGoogle Scholar
• Cleary M, Hunt G E, Matheson S, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008, Jan 23:CD001088
   PubMed Web of Science ®Google Scholar
• Cleary M, Hunt G E, Matheson S, Siegfried N, Walter G. Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Schizophr Bull 2008; 34: 226–8
   PubMed Web of Science ®Google Scholar
• Barrowclough C, Haddock G, Fitzsimmons M, Johnson R. Treatment development for psychosis and co-occurring substance misuse: a descriptive review. J Ment Health 2006; 15: 619–32
   Google Scholar
• Bogenschutz M P, Geppert C M, George J. The role of twelve-step approaches in dual diagnosis treatment and recovery. Am J Addict 2006; 15: 50–60
   PubMed Web of Science ®Google Scholar
• Donald M, Dower J, Kavanagh D. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Soc Sci Med 2005; 60: 1371–83
   PubMed Web of Science ®Google Scholar
• Drake R E, Mueser K T, Brunette M F, McHugo G J. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehab J 2004; 27: 360–74
   PubMed Web of Science ®Google Scholar
• Drake R E, O'Neal E L, Wallach M A. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008; 34: 123–38
   PubMed Web of Science ®Google Scholar
• Mueser K, Drake R, Sigmon S, Brunette M F. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: a review of specific interventions. J Dual Diagn 2005; 1: 57–82
   Google Scholar
• Tiet Q Q, Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 2007; 31: 513–36
   PubMed Web of Science ®Google Scholar
• Tsuang J, Fong T W, Lesser I. Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addict Disord Treat 2006; 5: 53–66
   Google Scholar
• Regier D A, Farmer M E, Rae D S, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990; 264: 2511–8
   PubMed Web of Science ®Google Scholar
• Kessler R C, Crum R M, Warner L A, Nelson C B, Schulenberg J, Anthony J C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–21
   PubMed Web of Science ®Google Scholar
• Moore T H, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–28
   PubMed Web of Science ®Google Scholar
• Hall W, Degenhardt L. Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 2007; 20: 393–7
   PubMed Web of Science ®Google Scholar
• Fowler I L, Carr V J, Carter N T, Lewin T J. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443–55
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–7
   PubMed Web of Science ®Google Scholar
• De Leon J, Susce M T, Diaz F J, Rendon D M, Velasquez D M. Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry 2005; 66: 1447–55
   PubMed Web of Science ®Google Scholar
• Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007; 27: 494–510
   PubMed Web of Science ®Google Scholar
• Bennett M E, Bellack A S, Gearon J S. Treating substance abuse in schizophrenia—an initial report. J Subst Abuse Treat 2001; 20: 163–75
   PubMed Web of Science ®Google Scholar
• Carey M P, Carey K B, Maisto S A, Schroder K E, Vanable P A, Gordon C M. HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender. J Nerv Ment Dis 2004; 192: 289–96
   PubMed Web of Science ®Google Scholar
• Dickey B, Azeni H, Weiss R, Sederer L. Schizophrenia, substance use disorders and medical co-morbidity. J Ment Health Policy Econ 2000; 3: 27–33
   PubMedGoogle Scholar
• Hawton K, Sutton L, Haw C, Sinclair J, Deeks J J. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry 2005; 187: 9–20
   PubMed Web of Science ®Google Scholar
• Hunt G E, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002; 54: 253–64
   PubMed Web of Science ®Google Scholar
• Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacol 2006; 187: 229–36
   PubMed Web of Science ®Google Scholar
• Pencer A, Addington J. Substance use and cognition in early psychosis. J Psychiatry Neurosci 2003; 28: 48–54
   PubMed Web of Science ®Google Scholar
• Potvin S, Pampoulova T, Mancini-Marie A, Lipp O, Bouchard R H, Stip E. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. J Neurol Neurosurg Psychiatry 2006; 77: 796–8
   PubMed Web of Science ®Google Scholar
• Todd J, Green G, Harrison M, et al. Social exclusion in clients with comorbid mental health and substance misuse problems. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 581–7
   PubMed Web of Science ®Google Scholar
• Ziedonis D M, Smelson D, Rosenthal R N, et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract 2005; 11: 315–39
   PubMedGoogle Scholar
• Green A I, Drake R E, Brunette M F, Noordsy D L. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry 2007; 164: 402–8
   PubMed Web of Science ®Google Scholar
• Cleary M, Hunt G E, Matheson S, Walter G. The association between substance use and the needs of patients with psychiatric disorder, levels of anxiety, and caregiving burden. Arch Psychiatr Nurs 2008; 22: 375–85
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11
   PubMed Web of Science ®Google Scholar
• Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–6
   PubMed Web of Science ®Google Scholar
• Fergusson D M, Horwood L J, Ridder E M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100: 354–66
   PubMed Web of Science ®Google Scholar
• Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96: 329–33
   PubMed Web of Science ®Google Scholar
• Shaffer H J, LaPlante D A, LaBrie R A, Kidman R C, Donato A N, Stanton M V. Toward a syndrome model of addiction: multiple expressions, common etiology. Harv Rev Psychiatry 2004; 12: 367–74
   PubMed Web of Science ®Google Scholar
• Hien D A, Cohen L R, Miele G M, Litt L C, Capstick C. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry 2004; 161: 1426–32
   PubMed Web of Science ®Google Scholar
• Cohen L R, Hien D A. Treatment outcomes for women with substance abuse and PTSD who have experienced complex trauma. Psychiatr Serv 2006; 57: 100–6
   PubMed Web of Science ®Google Scholar
• Briere J, Woo R, McRae B, Foltz J, Sitzman R. Lifetime victimization history, demographics, and clinical status in female psychiatric emergency room patients. J Nerv Ment Dis 1997; 185: 95–101
   PubMed Web of Science ®Google Scholar
• Brunette M F, Drake R E. Gender differences in patients with schizophrenia and substance abuse. Compr Psychiatry 1997; 38: 109–16
   PubMed Web of Science ®Google Scholar
• Morrissey J P, Jackson E W, Ellis A R, Amaro H, Brown V B, Najavits L M. Twelve-month outcomes of trauma-informed interventions for women with co-occurring disorders. Psychiatr Serv 2005; 56: 1213–22
   PubMed Web of Science ®Google Scholar
• Scheller-Gilkey G, Moynes K, Cooper I, Kant C, Miller A H. Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr Res 2004; 69: 167–74
   PubMed Web of Science ®Google Scholar
• Carey K B, Purnine D M, Maisto S A, Carey M P. Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention. Behav Modif 2001; 25: 331–84
   PubMed Web of Science ®Google Scholar
• Prochaska J O, DiClemente C C, Norcross J C. In search of how people change: applications to addcitive behaviors. Am Psychol 1992; 47: 1102–14
   PubMed Web of Science ®Google Scholar
• Bellack A S, DiClemente C C. Treating substance abuse among patients with schizophrenia. Psychiatr Serv 1999; 50: 75–80
   PubMed Web of Science ®Google Scholar
• Kavanagh D J, Young R, White A, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev 2004; 23: 151–5
   PubMed Web of Science ®Google Scholar
• Graeber D A, Moyers T B, Griffith G, Guajardo E, Tonigan S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Ment Health J 2003; 39: 189–202
   PubMed Web of Science ®Google Scholar
• Baker A, Bucci S, Lewin T J, Kay-Lambkin F, Constable P M, Carr V J. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. Br J Psychiatry 2006; 188: 439–48
   PubMed Web of Science ®Google Scholar
• Bellack A S, Bennett M E, Gearon J S, Brown C H, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006; 63: 426–32
   PubMed Web of Science ®Google Scholar
• Ries R K, Dyck D G, Short R, Srebnik D, Fisher A, Comtois K A. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatr Serv 2004; 55: 445–7
   PubMed Web of Science ®Google Scholar
• Drebing C E, Van Ormer E A, Krebs C, et al. The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. J Appl Behav Anal 2005; 38: 359–72
   PubMed Web of Science ®Google Scholar
• Clark R E. Family support and substance use outcomes for persons with mental illness and substance use disorders. Schizophr Bull 2001; 27: 93–101
   PubMed Web of Science ®Google Scholar
• Haddock G, Barrowclough C, Tarrier N, et al. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial. Br J Psychiatry 2003; 183: 418–26
   PubMed Web of Science ®Google Scholar
• Mueser K T, Drake R E, Bond G R. Recent advances in psychiatric rehabilitation for patients with severe mental illness. Harv Rev Psychiatry 1997; 5: 123–37
   PubMed Web of Science ®Google Scholar
• Jerrell J M, Ridgely M S. Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. J Nerv Ment Dis 1995; 183: 566–76
   PubMed Web of Science ®Google Scholar
• Magura S, Laudet A B, Mahmood D, Rosenblum A, Vogel H S, Knight E L. Role of self-help processes in achieving abstinence among dually diagnosed persons. Addict Behav 2003; 28: 399–413
   PubMed Web of Science ®Google Scholar
• Drake R E, McHugo G J, Clark R E, et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry 1998; 68: 201–15
   PubMed Web of Science ®Google Scholar
• McHugo G J, Drake R E, Teague G B, Xie H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatr Serv 1999; 50: 818–24
   PubMed Web of Science ®Google Scholar
• Essock S M, Mueser K T, Drake R E, et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatr Serv 2006; 57: 185–96
   PubMed Web of Science ®Google Scholar
• Brunette M F, Drake R E, Woods M, Hartnett T. A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatr Serv 2001; 52: 526–8
   PubMed Web of Science ®Google Scholar
• De Leon G, Sacks S, Staines G, McKendrick K. Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. Am J Drug Alcohol Abuse 2000; 26: 461–80
   PubMed Web of Science ®Google Scholar
• Sullivan C J, McKendrick K, Sacks S, Banks S. Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes. Am J Drug Alcohol Abuse 2007; 33: 823–32
   PubMed Web of Science ®Google Scholar
• Drake R E, McHugo G J, Xie H, Fox M, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull 2006; 32: 464–73
   PubMed Web of Science ®Google Scholar
• Barnes T R, Mutsatsa S H, Hutton S B, Watt H C, Joyce E M. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006; 188: 237–42
   PubMed Web of Science ®Google Scholar
• Kavanagh D J, Waghorn G, Jenner L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 2004; 66: 115–24
   PubMed Web of Science ®Google Scholar
• Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand 2006; 114: 109–17
   PubMed Web of Science ®Google Scholar
• Baker A, Bucci S, Lewin T J, Richmond R, Carr V J. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Res 2005; 134: 241–50
   PubMed Web of Science ®Google Scholar
• Barrowclough C, Haddock G, Tarrier N, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001; 158: 1706–13
   PubMed Web of Science ®Google Scholar
• Drake R E, McHugo G J, Noordsy D L. Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes. Am J Psychiatry 1993; 150: 328–9
   PubMed Web of Science ®Google Scholar
• Hellerstein D J, Rosenthal R N, Miner C R. A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients. Am J Addict 1995; 4: 33–42
   Web of Science ®Google Scholar
• Shaner A, Eckman T, Roberts L J, Fuller T. Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatr Serv 2003; 54: 1287–9
   PubMed Web of Science ®Google Scholar
• Drake R E, Yovetich N A, Bebout R R, Harris M, McHugo G J. Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis 1997; 185: 298–305
   PubMed Web of Science ®Google Scholar
• Lehman A F, Herron J D, Schwartz R P, Myers C P. Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial. J Nerv Ment Dis 1993; 181: 86–90
   PubMed Web of Science ®Google Scholar
• Weiss R D, Griffin M L, Greenfield S F, et al. Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clin Psychiatry 2000; 61: 361–7
   PubMed Web of Science ®Google Scholar
• Schmitz J M, Averill P, Sayre S, McCleary P, Moeller F G, Swann A. Cognitive-behavioral treatment of bipolar disorder and substance abuse: a preliminary randomized study. Addict Disord Treat 2002; 1: 17–24
   Google Scholar
• Brown R A, Evans D M, Miller I W, Burgess E S, Mueller T I. Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol 1997; 65: 715–26
   PubMed Web of Science ®Google Scholar
• Charney D A, Paraherakis A M, Gill K J. Integrated treatment of comorbid depression and substance use disorders. J Clin Psychiatry 2001; 62: 672–7
   PubMed Web of Science ®Google Scholar
• Velligan D I, Lam Y W, Glahn D C, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006; 32: 724–42
   PubMed Web of Science ®Google Scholar
• Graham H L. Implementing integrated treatment for co-existing substance use and severe mental health problems in assertive outreach teams: training issues. Drug Alcohol Rev 2004; 23: 463–70
   PubMed Web of Science ®Google Scholar
• Grella C E. Contrasting the views of substance misuse and mental health treatment providers on treating the dually diagnosed. Subst Use Misuse 2003; 38: 1433–46
   PubMed Web of Science ®Google Scholar